The Serum Institute of India should have quantities of COVID-19 vaccine, ready to sell into the private market in the first quarter of 2021, the institute’s head said, shortly after AstraZeneca’s announcement that its vaccine could be around 90% effective.
Sign in
Welcome! Log into your account
Forgot your password? Get help
Password recovery
Recover your password
A password will be e-mailed to you.